BR0016554A - Método e composição para tratamento e/ou prevenção de infecções de microorganismo resistentes à antibióticos - Google Patents

Método e composição para tratamento e/ou prevenção de infecções de microorganismo resistentes à antibióticos

Info

Publication number
BR0016554A
BR0016554A BR0016554-9A BR0016554A BR0016554A BR 0016554 A BR0016554 A BR 0016554A BR 0016554 A BR0016554 A BR 0016554A BR 0016554 A BR0016554 A BR 0016554A
Authority
BR
Brazil
Prior art keywords
composition
treating
antibiotic resistant
resistant microorganism
microorganism infections
Prior art date
Application number
BR0016554-9A
Other languages
English (en)
Inventor
Moussa S Diarra
Pierre Lacasse
Denis Petitclerc
Original Assignee
Majeste La Reine Du Chef Du Ca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Majeste La Reine Du Chef Du Ca filed Critical Majeste La Reine Du Chef Du Ca
Publication of BR0016554A publication Critical patent/BR0016554A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

"MéTODO E COMPOSIçãO PARA TRATAMENTO E/OU PREVENçãO DE INFECçõES DE MICROORGANISMO RESISTENTE A ANTIBIóTICOS". A presente invenção refere-se a uma nova composição, uso e método para melhorar a cura de infecções causadas por patógenos microbiais resistentes a antibióticos, em particular microorganismos resistentes a beta-lactam. Lactoferrina (LF) ou Lactoferricina (LFC) pode ser administrada sozinha ou em combinação com antibiótico para afetar o desenvolvimento, a fisiologia e a morfologia do microorganismo alvo. A lactoferrina aumenta a susceptibilidade e pode reverter a resistência de microorganismos a antibióticos.
BR0016554-9A 1999-12-20 2000-12-19 Método e composição para tratamento e/ou prevenção de infecções de microorganismo resistentes à antibióticos BR0016554A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17257799P 1999-12-20 1999-12-20
PCT/CA2000/001517 WO2001045732A2 (en) 1999-12-20 2000-12-19 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections

Publications (1)

Publication Number Publication Date
BR0016554A true BR0016554A (pt) 2003-02-11

Family

ID=22628296

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0016554-9A BR0016554A (pt) 1999-12-20 2000-12-19 Método e composição para tratamento e/ou prevenção de infecções de microorganismo resistentes à antibióticos

Country Status (15)

Country Link
US (3) US20030134779A1 (pt)
EP (1) EP1246640B1 (pt)
JP (1) JP2003518072A (pt)
AT (1) ATE323506T1 (pt)
AU (1) AU782915B2 (pt)
BR (1) BR0016554A (pt)
CA (1) CA2394997A1 (pt)
DE (1) DE60027472T2 (pt)
DK (1) DK1246640T3 (pt)
ES (1) ES2262555T3 (pt)
HK (1) HK1050628B (pt)
IL (2) IL150361A0 (pt)
MX (1) MXPA02006143A (pt)
PT (1) PT1246640E (pt)
WO (1) WO2001045732A2 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786787B1 (fr) * 1998-12-08 2002-04-19 Proteus Methode d'analyse in vitro d'un phenotype connu a partir d'un echantillon d'acides nucleiques
EP1303256B1 (en) * 2000-06-09 2009-01-07 Baylor College of Medicine The combination of antimicrobial agents and bacterial interference to coat medical devices
DE202004006282U1 (de) * 2004-04-19 2004-07-01 Lohmann Animal Health Gmbh & Co. Kg Vorrichtung für die Empfindlichkeitsprüfung bakterieller Infektionserreger und Impfstämme des Geflügels
ES2731298T3 (es) 2005-05-27 2019-11-14 Univ North Carolina Chapel Hill Partículas de liberación de óxido nítrico para agentes terapéuticos de óxido nítrico y aplicaciones biomédicas
JP5087297B2 (ja) * 2007-03-05 2012-12-05 森永乳業株式会社 インターロイキン−１１産生促進剤
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
US20120122819A1 (en) * 2009-06-12 2012-05-17 Socpra - Sciences Et Genie S.E.C. Guanine riboswitch binding compounds and their use as antibiotics
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
US10273294B2 (en) 2010-10-11 2019-04-30 University Of Southern California Compositions and methods for treating HIF-1α over-expressing cancers
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
CA2826192A1 (en) 2011-01-31 2012-08-09 The Government Of The United States, As Represented By The Secretary Of The Army Methods and compositions for treating bacterial infections with iron chelators
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
JPWO2016056665A1 (ja) * 2014-10-08 2017-08-10 学校法人慶應義塾 白血球の細胞外トラップ形成の阻害剤
JP7458622B2 (ja) * 2019-09-18 2024-04-01 学校法人東京農業大学 抗生物質耐性微生物の耐性を低下させる物質及び抗生物質耐性微生物の耐性を低下させる方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4304855A (en) * 1977-05-05 1981-12-08 The Upjohn Company Allylic methyl-hydroxylated novobiocins
US5198419A (en) * 1989-12-08 1993-03-30 Immuno Japan Inc. Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
JPH0748274A (ja) * 1991-06-26 1995-02-21 Immuno Japan:Kk 養殖漁業における病原微生物感染症の予防並びに治療用飼料の製法
DE69220679T2 (de) * 1992-01-23 1997-10-23 Morinaga Milk Industry Co. Ltd., Tokio/Tokyo Antibakterielles mittel und behandlung von gegenständen mit diesem
FR2713240B1 (fr) * 1993-12-02 1996-03-01 Bio Merieux Milieu nutritif pour la culture de microorganismes.
US5834424A (en) * 1995-07-12 1998-11-10 Gambit International Limited Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6407091B1 (en) * 1999-04-15 2002-06-18 Research Corporation Technologies, Inc. β-lactamase inhibiting compounds

Also Published As

Publication number Publication date
US20080207491A1 (en) 2008-08-28
EP1246640B1 (en) 2006-04-19
US20030134779A1 (en) 2003-07-17
AU782915B2 (en) 2005-09-08
IL150361A0 (en) 2002-12-01
DK1246640T3 (da) 2006-08-21
ES2262555T3 (es) 2006-12-01
MXPA02006143A (es) 2004-08-23
EP1246640A2 (en) 2002-10-09
HK1050628B (zh) 2006-10-20
WO2001045732A2 (en) 2001-06-28
IL150361A (en) 2008-04-13
PT1246640E (pt) 2006-07-31
DE60027472D1 (de) 2006-05-24
ATE323506T1 (de) 2006-05-15
HK1050628A1 (en) 2003-07-04
AU2334901A (en) 2001-07-03
CA2394997A1 (en) 2001-06-28
DE60027472T2 (de) 2006-12-07
JP2003518072A (ja) 2003-06-03
WO2001045732A3 (en) 2001-12-06
US20060142183A1 (en) 2006-06-29

Similar Documents

Publication Publication Date Title
BR0016554A (pt) Método e composição para tratamento e/ou prevenção de infecções de microorganismo resistentes à antibióticos
ATE219684T1 (de) Anti gram positive bakterielle verfahren und mittel
NO991548D0 (no) Anvendelse av mupirocin for fremstilling av et medikament for behandling av bakterieinfeksjoner forÕrsaket i forbindelse med kolonisering av nasofarynks med patogene organismer
ATE491026T1 (de) Ply-gbs-lysinmutanten
PT1165058E (pt) Antibioticos azalido para o tratamento ou prevencao topicos de infeccoes oculares
TW200507841A (en) Antibacterial agents
PH12020550941A1 (en) Methods and compositions to prevent microbial infection
PT1216256E (pt) Antibioticos macrolidos e tratamento de pasteurelose
EP1618106A4 (en) CARBACEPHEM LACTAM ANTIBIOTICS
WO2004060272A3 (en) Delivery of peroxide-generating enzymes to the vaginal tract
DE60207884D1 (de) Monobactam-antibakterielle verbindungen und anwendungsverfahren
DE60104815D1 (de) Bakteriophagen-assoziierte lytische enzyme zur therapeutischen behandlung von bakteriellen infektionen
MX2023012943A (es) Compuesto antibacteriano.
ATE367164T1 (de) Verwendung von 4-thiouridin oder isomaltitol zur behandlung von entzündungen und/oder hämostasis
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
Rahman et al. Identification of aerobic organisms associated with oral and maxillofacial surgery: A study in Bangladesh
Nordmann Antimicrobial susceptibility of human isolates of Rhodococcus equi
KRISHNA PADMASANI VENKAT RAMANAN, SHALINI SHARMA, and
UA51607A (uk) Спосіб моделювання гострого брижового лімфаденіту

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]